These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8847550)

  • 1. Free radical damage, iron, and Alzheimer's disease.
    Smith MA; Perry G
    J Neurol Sci; 1995 Dec; 134 Suppl():92-4. PubMed ID: 8847550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
    Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the possible role of iron-induced free radical peroxidation in neural degeneration in Alzheimer's disease.
    Richardson JS; Subbarao KV; Ang LC
    Ann N Y Acad Sci; 1992 May; 648():326-7. PubMed ID: 1322084
    [No Abstract]   [Full Text] [Related]  

  • 4. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.
    Smith MA; Harris PL; Sayre LM; Perry G
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9866-8. PubMed ID: 9275217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
    Varadarajan S; Yatin S; Aksenova M; Butterfield DA
    J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences.
    Butterfield DA
    Curr Med Chem; 2003 Dec; 10(24):2651-9. PubMed ID: 14529455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical AGEing in Alzheimer's disease.
    Smith MA; Sayre LM; Monnier VM; Perry G
    Trends Neurosci; 1995 Apr; 18(4):172-6. PubMed ID: 7778188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress in Alzheimer's disease.
    Smith MA; Rottkamp CA; Nunomura A; Raina AK; Perry G
    Biochim Biophys Acta; 2000 Jul; 1502(1):139-44. PubMed ID: 10899439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free radicals in Alzheimer's disease.
    Retz W; Gsell W; Münch G; Rösler M; Riederer P
    J Neural Transm Suppl; 1998; 54():221-36. PubMed ID: 9850931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection].
    Behl C; Holsboer F
    Fortschr Neurol Psychiatr; 1998 Mar; 66(3):113-21. PubMed ID: 9565761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
    Mattson MP
    Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: fundamental and therapeutic aspects.
    Schorderet M
    Experientia; 1995 Feb; 51(2):99-105. PubMed ID: 7875258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is brain copper deficiency in Alzheimer's, Lewy body, and Creutzfeldt Jakob diseases the common key for a free radical mechanism and oxidative stress-induced damage?
    Deloncle R; Guillard O
    J Alzheimers Dis; 2015; 43(4):1149-56. PubMed ID: 25125459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and redox-active iron in Alzheimer's disease.
    Honda K; Casadesus G; Petersen RB; Perry G; Smith MA
    Ann N Y Acad Sci; 2004 Mar; 1012():179-82. PubMed ID: 15105265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative alterations in Alzheimer's disease.
    Markesbery WR; Carney JM
    Brain Pathol; 1999 Jan; 9(1):133-46. PubMed ID: 9989456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alzheimer dementia: more than amyloid plaques and neurofibrillary degeneration].
    Bauer J
    Fortschr Med; 1994 Mar; 112(7):81-4. PubMed ID: 8175096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer disease and the role of free radicals in the pathogenesis of the disease.
    Moreira PI; Santos MS; Oliveira CR; Shenk JC; Nunomura A; Smith MA; Zhu X; Perry G
    CNS Neurol Disord Drug Targets; 2008 Feb; 7(1):3-10. PubMed ID: 18289026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiopathology of dementia of the Alzheimer type: role of the amyloid beta-protein].
    Lamour Y
    Ann Med Psychol (Paris); 1992; 150(2-3):131-7. PubMed ID: 1343507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis.
    Leveugle B; Spik G; Perl DP; Bouras C; Fillit HM; Hof PR
    Brain Res; 1994 Jul; 650(1):20-31. PubMed ID: 7953673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E and other antioxidants in neuroprotection.
    Behl C
    Int J Vitam Nutr Res; 1999 May; 69(3):213-9. PubMed ID: 10389030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.